期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Melatonin and derivatives as promising tools for glaucoma treatment
1
作者 Hanan Awad Alkozi jesús pintor 《World Journal of Ophthalmology》 2013年第4期32-37,共6页
Neurohormones melatonin and its analogues are present with an important physiological and pharmacological ability to reduce intraocular pressure(IOP); thus, they are suitable for the treatment of ocular hypertension o... Neurohormones melatonin and its analogues are present with an important physiological and pharmacological ability to reduce intraocular pressure(IOP); thus, they are suitable for the treatment of ocular hypertension often associated with glaucoma. It is demonstrated that two of its analogues, 5-MCA-NAT and IIK7, are more effective than melatonin to reduce IOP for a longer period of time. The research for the discovery of better compounds resulted in the development of newer and improved analogues compared to 5-MCA-NAT and IIK7. Furthermore, already commercially available drugs currently used as treatment for other pathologies, presenting a resemblance to the melatonin structure, are being tested as potential glaucoma drugs. In this sense, agomelatine, which is already used as an anti-depressant medicine, is recognized as a worthy candidate since it reduces IOP, even under hypertensive conditions. To sum up, the use of melatonin and its analogues as promising anti-glaucomatous substances is of great importance and should be given serious consideration. 展开更多
关键词 5-MCA-NAT IIK7 GLAUCOMA OCULAR HYPERTENSION MELATONIN
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部